SF3B1 and myelodysplastic syndrome: Pathogenic SF3B1 mutations are most frequent in myelodysplastic syndromes (MDS) and are also found in acute myeloid leukemia (AML), chronic lymphocytic leukemia (CLL) and several solid tumors, such as breast cancer (BRCA) and uveal melanoma (UVM) [4–9].